75.43
price down icon2.62%   -2.03
pre-market  시장 영업 전:  74.01   -1.42   -1.88%
loading

Nuvalent Inc 주식(NUVL)의 최신 뉴스

pulisher
May 05, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Stock Holdings Lowered by Envestnet Asset Management Inc. - Defense World

May 05, 2025
pulisher
May 03, 2025

When the Price of (NUVL) Talks, People Listen - news.stocktradersdaily.com

May 03, 2025
pulisher
May 02, 2025

Nuvalent Inc (NUVL) looking to reclaim success with recent performance - Sete News

May 02, 2025
pulisher
May 01, 2025

Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter 2023 Financial Results - Seeking Alpha

May 01, 2025
pulisher
Apr 29, 2025

Nuvalent reveals preclinical data on cancer drug zidesamtinib - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

Nuvalent Announces Publication in Molecular Cancer Therapeutics - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Nuvalent Announces Publication in Molecular Cancer Therapeutics Reinforcing Rational Molecular Design of Zidesamtinib as a Novel ROS1-Selective Inhibitor - PR Newswire

Apr 29, 2025
pulisher
Apr 29, 2025

Indo-Asian News Service - Indo-Asian News Service (IANS)

Apr 29, 2025
pulisher
Apr 27, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Position Boosted by Wells Fargo & Company MN - Defense World

Apr 27, 2025
pulisher
Apr 26, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Apr 26, 2025
pulisher
Apr 23, 2025

Nuvalent, Inc. (NUVL): Among Takeover Rumors Hedge Funds Are Buying - Yahoo Finance

Apr 23, 2025
pulisher
Apr 23, 2025

Is Nuvalent, Inc. (NUVL) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Insider Monkey

Apr 23, 2025
pulisher
Apr 23, 2025

Nuvalent to Present Trial in Progress Posters for the ALKAZAR Trial of Neladalkib and HEROEX-1 Trial of NVL-330 at the 2025 American Society of Clinical Oncology Annual Meeting - The Malaysian Reserve

Apr 23, 2025
pulisher
Apr 22, 2025

Nuvalent describes new ROS and ALK tyrosine kinase receptor inhibitors - BioWorld MedTech

Apr 22, 2025
pulisher
Apr 21, 2025

UBS gives a Buy recommendation for Nuvalent Inc (NUVL) - knoxdaily.com

Apr 21, 2025
pulisher
Apr 18, 2025

JPMorgan Chase & Co. Acquires 47,818 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 18, 2025
pulisher
Apr 18, 2025

Trend Tracker for (NUVL) - news.stocktradersdaily.com

Apr 18, 2025
pulisher
Apr 17, 2025

Nuvalent Board Member Resigns, Joins Advisory Board - TipRanks

Apr 17, 2025
pulisher
Apr 16, 2025

Alliancebernstein L.P. Purchases 500 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 16, 2025
pulisher
Apr 11, 2025

Commonwealth Equity Services LLC Raises Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Sei Investments Co. Reduces Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 10, 2025
pulisher
Apr 08, 2025

Nuvalent: Cannot Make Sense Of The Valuation - Seeking Alpha

Apr 08, 2025
pulisher
Apr 07, 2025

Nuvalent stock touches 52-week low at $61.75 amid market shifts By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Nuvalent stock touches 52-week low at $61.75 amid market shifts - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

Norges Bank Invests $24.95 Million in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 07, 2025
pulisher
Apr 03, 2025

KLP Kapitalforvaltning AS Buys New Shares in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

What to Expect at AACR 2025: Nuvalent to present Data on Neladalkib and Zidesamtinib - Onco'Zine

Apr 02, 2025
pulisher
Apr 02, 2025

Commit To Purchase Nuvalent At $55, Earn 11.9% Annualized Using Options - Nasdaq

Apr 02, 2025
pulisher
Apr 01, 2025

(NUVL) On The My Stocks Page - news.stocktradersdaily.com

Apr 01, 2025
pulisher
Apr 01, 2025

Is Nuvalent (NUVL) the Best Debt Free Mid Cap Stock to Buy Now? - Yahoo

Apr 01, 2025
pulisher
Apr 01, 2025

Nuvalent to Participate in the Stifel 2025 Virtual Targeted Oncology Forum - Quantisnow

Apr 01, 2025
pulisher
Apr 01, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Apr 01, 2025
pulisher
Mar 30, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Stake Cut by Virtu Financial LLC - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Teacher Retirement System of Texas Boosts Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

Why Nuvalent (NUVL) Is Among the Best Mid Cap Biotech Stocks to Buy - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

Nuvalent chief development officer sells shares worth $292,468 By Investing.com - Investing.com Philippines

Mar 29, 2025
pulisher
Mar 29, 2025

10 Best Debt Free Mid Cap Stocks to Buy Now - Insider Monkey

Mar 29, 2025
pulisher
Mar 28, 2025

Nuvalent chief development officer sells shares worth $292,468 - Investing.com India

Mar 28, 2025
pulisher
Mar 26, 2025

10 Best Mid Cap Biotech Stocks to Buy - Insider Monkey

Mar 26, 2025
pulisher
Mar 25, 2025

Nuvalent to Present New Preclinical Data on ALK-Selective Inhibitor, Neladalkib, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2025 - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

Breakthrough Cancer Drug Data: New Brain-Penetrant Therapy Shows Promise Against Resistant Tumors - Stock Titan

Mar 25, 2025
pulisher
Mar 24, 2025

Recent Insider Activity Suggests Potential Gains for Nuvalent Inc (NUVL) - knoxdaily.com

Mar 24, 2025
pulisher
Mar 22, 2025

How the (NUVL) price action is used to our Advantage - news.stocktradersdaily.com

Mar 22, 2025
pulisher
Mar 21, 2025

Raymond James Financial Inc. Acquires Shares of 133,964 Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Connor Clark & Lunn Investment Management Ltd. Sells 18,609 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - The AM Reporter

Mar 21, 2025
pulisher
Mar 19, 2025

Nuvalent CEO Porter sells $2.05 million in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Nuvalent CEO Porter sells $2.05 million in stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Victory Capital Management Inc. Cuts Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

Charles Schwab Investment Management Inc. Buys 7,742 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

US Bancorp DE Invests $90,000 in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 18, 2025
pulisher
Mar 15, 2025

Bank of New York Mellon Corp Increases Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

UBS Upgrades Nuvalent (NUVL) - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

Nuvalent upgraded to Buy from Neutral at UBS - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

UBS Upgrades Nuvalent to Buy From Neutral, Maintains $100 Price Target -March 14, 2025 at 07:24 am EDT - Marketscreener.com

Mar 14, 2025
pulisher
Mar 08, 2025

Principal Financial Group Inc. Cuts Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 08, 2025
$72.58
price up icon 0.39%
$21.55
price up icon 0.33%
$33.00
price up icon 0.33%
$28.02
price up icon 0.43%
$101.10
price down icon 3.66%
biotechnology ONC
$254.16
price down icon 0.63%
자본화:     |  볼륨(24시간):